Use of a maturity model for facilitating the introduction of CAR T-cell therapy-Results of the START CAR-T project
{{output}}
Introduction: Chimeric antigen receptor (CAR) T-cell therapies are novel immunotherapies for the treatment of hematologic malignancies. They are administered in specialized centers by a multidisciplinary team and require the care... ...
